Biomaterials have played an increasingly prominent role in the success of biomedical
devices and in the development of tissue engineering, which seeks to unlock the …

Heart disease is the main cause of death worldwide. Because death of the myocardium is
irreversible, it remains a significant clinical challenge to rescue myocardial deficiency …

Biofabrication of cell supportive cardiac patches that can be directly implanted on
myocardial infarct is a potential solution for myocardial infarction repair. Ideally, cardiac …

Cardiovascular disease is a leading cause of mortality in the world and is exacerbated by
the presence of cardiac fibrosis, defined by the accumulation of noncontractile extracellular …

In recent years, clinical applications have been proposed for various hydrogel products.
Hydrogels can be derived from animal tissues, plant extracts and/or adipose tissue …

Cardiovascular disease is one of the leading causes of mortality worldwide. Cardiac tissue
engineering strategies focusing on biomaterial scaffolds incorporating cells and growth …

Heart failure initiated by coronary artery disease and myocardial infarction (MI) is a
widespread, debilitating condition for which there are a limited number of options to prevent …

Transplantation of stem cells into the heart can improve cardiac function after myocardial
infarction and in chronic heart failure, but the extent of benefit and of reproducibility of this …

Stem cells are a promising solution for the treatment of a variety of diseases. However, the
limited survival and engraftment of transplanted cells due to a hostile ischemic environment …

Injectable biomaterials offer a non-invasive approach to deliver cells into the myocardial
infarct region to maintain a high level of cell retention and viability and initiate the …